Study: There are major risks to taking niacin for cholesterol issues
More than 700,000 prescriptions are written for niacin each month in the United States, but a new study finds that the pills might do more harm than good.
Niacin is a B vitamin, and is often given to patients who need to lower their "bad" cholesterol while raising the "good" kind. Researchers at Oxford University studied more than 25,000 people in Europe and China who took niacin while undergoing standard cholesterol treatment. The "bad" cholesterol (LDL) did decrease, but the niacin was also linked to a 32 percent increase in diabetes over four years. There were other side effects, like bleeding, heartburn, and stomach ulcers, and taking niacin didn't seem to lower rates of chest pain, stroke, or heart attack.
"On the basis of the weight of available evidence showing net clinical harm, niacin must be considered to have an unacceptable toxicity profile for the majority of patients, and it should not be used routinely," Dr. Donald Lloyd-Hones of Northwestern University's Feinberg School of Medicine wrote in a commentary. The Mayo Clinic still recommends taking niacin, but only after consulting with a doctor.
The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
The report was published Wednesday in the New England Journal of Medicine.
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Catherine Garcia has worked as a senior writer at The Week since 2014. Her writing and reporting have appeared in Entertainment Weekly, The New York Times, Wirecutter, NBC News and "The Book of Jezebel," among others. She's a graduate of the University of Redlands and the Columbia University Graduate School of Journalism.
-
FDA OKs generic abortion pill, riling the rightSpeed Read The drug in question is a generic version of mifepristone, used to carry out two-thirds of US abortions
-
RFK Jr. vaccine panel advises restricting MMRV shotSpeed Read The committee voted to restrict access to a childhood vaccine against chickenpox
-
Texas declares end to measles outbreakSpeed Read The vaccine-preventable disease is still spreading in neighboring states, Mexico and Canada
-
RFK Jr. shuts down mRNA vaccine funding at agencySpeed Read The decision canceled or modified 22 projects, primarily for work on vaccines and therapeutics for respiratory viruses
-
Measles cases surge to 33-year highSpeed Read The infection was declared eliminated from the US in 2000 but has seen a resurgence amid vaccine hesitancy
-
Kennedy's vaccine panel signals skepticism, changeSpeed Read RFK Jr.'s new vaccine advisory board intends to make changes to the decades-old US immunization system
-
Kennedy ousts entire CDC vaccine advisory panelspeed read Health Secretary RFK Jr. is a longtime anti-vaccine activist who has criticized the panel of experts
-
RFK Jr. scraps Covid shots for pregnant women, kidsSpeed Read The Health Secretary announced a policy change without informing CDC officials



